Denosumab may reduce hypercalcaemia after transplantation for osteopetrosisBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7477 (Published 07 November 2012) Cite this as: BMJ 2012;345:e7477
In osteopetrosis, defective osteoclasts impair bone resorption and excessive bone is formed. Haematopoietic stem cell transplantation is the only cure for this rare inherited disorder, but it is …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial